期刊文献+

阿托伐他汀对冠心病患者血脂及血管内皮功能的影响 被引量:1

Atorvastatin on Blood Lipids in Patients with Coronary Heart Disease and Vascular Endothelial Function
原文传递
导出
摘要 目的探讨阿托伐他汀对冠心病患者血脂及血管内皮功能的影响。方法选自2006年1月—2009年5月南阳市油田总医院门诊或住院冠心病并血脂异常患者186例。选用不同剂量阿托伐他汀进行治疗,观察疗效及治疗前和治疗后总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、肱动脉流量介导性舒张(Flow-mediated dilation,FMD)功能检测。结果所有病例均顺利完成全部疗程的治疗,无中途停药和不配合治疗,其中A组总有效率85.5%,B组总有效率95.83%。结论阿托伐他汀为强效的调脂新药,临床疗效确切,安全可靠。除有较强的调脂作用外,还具有强大的改善血管内皮功能的作用。 Objective To investigate the effect of atorvastatin on blood lipids in patients with coronary heart disease and vascular endothelial function.Methods Taken from January 2006-2009 year in May out-patient or in-patient with coronary heart disease and 186 cases of patients with dyslipidemia.Use of different doses of atorvastatin treatment,observation and treatment to determine efficacy before and after treatment total cholesterol(TC),triglyceride(TG),high-density lipoprotein cholesterol(HDL-C),low-density lipoprotein cholesterol(LDL-C),brachial artery flow-mediated dilation(Flow-mediated dilation,FMD) function tests.Results All patients were successfully complete a full course of treatment,no half-way with treatment discontinuation and non-A group,the total efficiency of 85.5%,B group,the total efficiency of 95.83%.Conclusion Atorvastatin potent lipid-lowering drugs,the clinical curative effect,safe and reliable.In addition there is a strong lipid,but also with a strong improvement in endothelial function.
作者 文斌
出处 《医药论坛杂志》 2010年第6期37-39,共3页 Journal of Medical Forum
关键词 阿托伐他汀 冠心病 血脂 血管内皮功能 影响 Atorvastatin Coronary heart disease Blood lipids Vascular endothelial function Impact
  • 相关文献

参考文献6

二级参考文献28

  • 1王新华.他汀类药物与冠心病的防治[J].现代医药卫生,2005,21(21):2922-2924. 被引量:1
  • 2The Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol in 4 444 patients with conronary heart disease:The Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344(4):1 383-1 389.
  • 3Rajagopalan S,J Clin Invest,1996年,98卷,2572页
  • 4Shab P K,Circulation,1995年,92卷,1565页
  • 5Peng H B,J Bio Chem,1995年,270卷,14214页
  • 6De Caterinar,J Clin Invest,1995年,96卷,60页
  • 7Unger T,J Cardiovase Pharmacol,1994年,6卷,872页
  • 8Sorensen MB, Collins P, Ong PJ, et al. Circulation, 2002;106(13) :1 646~1 651
  • 9Inoue T, Hayashi M, Takayanagi K, et al. Atherosclerosis,2002 ; 160(2) :369~376
  • 10Sommeijer DW, MacGillavry MR, Meijers JC, et al. Diabetes Care, 2004;27(2) :468~473

共引文献33

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部